PRL and metabolic disease: Regarding the long-term effects of bromocriptine, its daily administration has been reported to ameliorate glucose metabolism in various animal models of metabolic disorders, including genetically obese ob/ob mice, diet-induced obese melanocortin-4 receptor knockout and prolactin knockout mice, and dogs fed HFD [8–11,13,42,43].